Preventive treatment for migraine in primary care, a population-based study in the Netherlands

Cephalalgia

Volumn 33, Issue 14, 2013, Pages 1170-1178

  Dekker, F ^a   Dieleman, J P ^b   Neven, A Knuistingh ^a   Ferrari, M D ^a   Assendelft, Wjj ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

headache; incidence; medication overuse headache; Migraine; preventive treatment; prophylaxis

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ATENOLOL; ERGOT DERIVATIVE; FLUNARIZINE; METHYSERGIDE; METOPROLOL; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIZOTIFEN; TOPIRAMATE; TRIPTAN DERIVATIVE; VALPROIC ACID; VERAPAMIL;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; DRUG INDUCED HEADACHE; FEMALE; GENERAL PRACTICE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MENSTRUAL MIGRAINE; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NETHERLANDS; POPULATION RESEARCH; PRESCHOOL CHILD; PRESCRIPTION; PRIMARY MEDICAL CARE; REFERENCE DATABASE; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT DURATION;

HEADACHE; INCIDENCE; MEDICATION-OVERUSE HEADACHE; MIGRAINE; PREVENTIVE TREATMENT; PROPHYLAXIS;

ADOLESCENT; ADULT; AGED; CHILD; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NETHERLANDS; POPULATION SURVEILLANCE; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84885010771     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102413490343     Document Type: Article

References (31)

1. Ferrari MD. Migraine. Lancet. 1998 ; 351: 1043-1051
2. Atlas of headache disorders and resources in the world 2011. Geneva: WHO ; 2011 :
3. Grol MH, Neven AK, Pijnenborg L, et al. Summary of the practice guideline 'Headache' from the Dutch College of General Practitioners [in Dutch]. Ned Tijdschr Geneeskd. 2006 ; 150: 305-309
4. Couturier EG, Bomhof MA, Gooskens R, et al Richtlijnen diagnostiek en behandeling chronisch recidiverende hoofdpijn zonder neurologische afwijkingen. Utrecht: Nederlandse Vereniging voor Neurologie ; 2008 :
5. Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine - report of an EFNS task force. Eur J Neurol. 2006 ; 13: 560-572
6. Modi S, Lowder DM. Medications for migraine prophylaxis. Am Fam Physician. 2006 ; 73: 72-78
7. Lipton RB, Bigal ME. Ten lessons on the epidemiology of migraine. Headache. 2007 ; 47: S2 - S9
8. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007 ; 68: 343-349
9. Lipton RB, Scher AI, Kolodner K, et al. Migraine in the United States: Epidemiology and patterns of health care use. Neurology. 2002 ; 58: 885-894
10. Diamond S, Bigal ME, Silberstein S, et al. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: Results from the American Migraine Prevalence and Prevention study. Headache. 2007 ; 47: 355-363
11. Lucas C, Chaffaut C, Artaz MA, et al. FRAMIG 2000: Medical and therapeutic management of migraine in France. Cephalalgia. 2005 ; 25: 267-279
12. Kol CM, Dekker F, Neven AK, et al. Acceptance or rejection of prophylactic medicine in patients with migraine: A cross-sectional study. Br J Gen Pract. 2008 ; 58: 98-101
13. Dekker F, Wiendels N, de Valk V, et al. Triptan overuse in the Dutch general population: A nationwide pharmaco-epidemiology database analysis in 6.7 million people. Cephalalgia. 2011 ; 31: 943-952
14. Wiendels NJ, Knuistingh Neven A, Rosendaal FR, et al. Chronic frequent headache in the general population: Prevalence and associated factors. Cephalalgia. 2006 ; 26: 1434-1442
15. Wiendels NJ, van Haestregt A, Knuistingh Neven A, et al. Chronic frequent headache in the general population: Comorbidity and quality of life. Cephalalgia. 2006 ; 26: 1443-1450
16. Okkes I, Jamoulle M, Lamberts H, et al. ICPC-2-E: The electronic version of ICPC-2. Differences from the printed version and the consequences. Fam Pract. 2000 ; 17: 101-107
17. ICPC-2 International classification of primary care. 2 International classification of primary care, 2nd edn. Oxford: Oxford University Press, 1998. Oxford: Oxford University Press ; 1998 :
18. Guidelines for ATC classification and DDD assignment. Oslo: WHO ; 1998 :
19. Vlug AE, van der Lei J, Mosseveld BM, et al. Postmarketing surveillance based on electronic patient records: The IPCI project. Methods Inf Med. 1999 ; 38: 339-344
20. The International Classification of Headache Disorders. Cephalalgia. 2004 ; 24: 9-160
21. Dekker F, Knuistingh NA, Andriesse B, et al. Prophylactic treatment of migraine; the patient's view, a qualitative study. BMC Fam Pract. 2012 ; 13: 13-13
22. Schuurmans A, van Weel C. Pharmacologic treatment of migraine. Comparison of guidelines. Can Fam Physician. 2005 ; 51: 838-843
23. Antonaci F, Dumitrache C, De Cillis I, et al. A review of current European treatment guidelines for migraine. J Headache Pain. 2010 ; 11: 13-19
24. Rahimtoola H, Buurma H, Tijssen CC, et al. Incidence and determinants of migraine prophylactic medication in the Netherlands. Eur J Clin Pharmacol. 2002 ; 58: 149-155
25. Rahimtoola H, Buurma H, Tijssen CC, et al. Migraine prophylactic medication usage patterns in the Netherlands. Cephalalgia. 2003 ; 23: 293-301
26. Cevoli S, D'Amico D, Martelletti P, et al. Underdiagnosis and undertreatment of migraine in Italy: A survey of patients attending for the first time 10 headache centres. Cephalalgia. 2009 ; 29: 1285-1293
27. Lafata J, Tunceli O, Cerghet M, et al. The use of migraine preventive medications among patients with and without migraine headaches. Cephalalgia. 2010 ; 30: 97-104
28. Berger A, Bloudek LM, Varon SF, et al. Adherence with migraine prophylaxis in clinical practice. Pain Pract. 2012 ; 12: 541-549
29. Valade D, Lantéri-Minet M, Radat F, et al. Clinical determinants of migraine preventive treatment: Contribution of SMILE, an observational survey of primary care migraine management in France. Cephalalgia. 2010 ; 30: 1207-1213
30. Zielman R, Veenstra P, Zwet E, et al. How general practitioners treat migraine patients: Evaluation of a headache guideline. Cephalalgia. 2012 ; 32: 908-915
31. Linde K and Rossnagel K. Propranolol for migraine prophylaxis. Cochrane Database Syst Rev 2004: CD003225.